Fig. 5: OLIG2 inhibition blocks SOX2+ MB stem cell activation. | Nature Communications

Fig. 5: OLIG2 inhibition blocks SOX2+ MB stem cell activation.

From: OLIG2 mediates a rare targetable stem cell fate transition in sonic hedgehog medulloblastoma

Fig. 5

a Volcano plot comparing fold change (x-axis) and false discovery rate (y-axis) obtained from EdgeR analysis of the differentially expressed genes between IC50 (189.2 nM) CT-179 or vehicle treatment of Ptch1+/−;Trp53−/− (PTCP53 304) mouse tumour cells for 6 days. b Relative fold change expression of select genes in vehicle and CT-179 treated cells from dataset shown in (a); n = 3 biological replicates, error bars denote mean ± SEM; two-tailed unpaired t-test; ns p ≥ 0.05, *p < 0.05, **p < 0.01. c, d Representative immunofluorescence (IF) images of endogenous SOX2, OLIG2, and EdU in early (c) or late (d) neoplastic lesions of mice sacrificed after 7 days of continuous EdU label in the presence of either vehicle (dH2O) or CT-179 daily injections. Scale bar: 50 µM for 20X and 25 µM for 40X. e Quantification of the fraction of SOX2 + cells and of EdU incorporation in (c) relative to DAPI+ cells. n = 4 for CT-179, n = 3 for vehicle; error bars denote mean ± SEM; two-tailed unpaired t-test. unpaired t-test; *p < 0.05, ****p < 0.0001; p = 0.0240 (SOX2+), p = 0.0081 (OLIG2+/EdU+). f Quantification of the fraction of SOX2+ or SOX2+ and OLIG2+ cells that have incorporated EdU in (d). n = 3 for CT-179, n = 3 for vehicle; error bars denote mean ± SEM; two-tailed unpaired t-test; **p < 0.01, ***p < 0.001; p = 0.0006 (EdU+), p < 0.0001 (EdU+). g Representative immunofluorescence (IF) images of endogenous SOX2, EdU, and BrdU in early neoplastic lesions in mice sacrificed after 4 days of EdU label followed by an 8-day chase period of which 7 days were treatment with either vehicle (dH2O) or CT-179 by daily IP injections, followed by a single BrdU pulse. Scale bar: 50 µM for 20X and 25µM for 40X. SOX2+/EdU+ cells are indicated with white arrows in the 40x image, while the yellow arrow indicates a triple positive cell (SOX2+/EdU+/BrdU+). h Quantification of the fraction of SOX2+ cells that have incorporated EdU or BrdU as represented in (g). For the quantification, 8 independent lesions were evaluated from 3 mouse brains for each treatment condition (vehicle or CT-179); error bars denote mean ± SEM; two-tailed unpaired t-test; ns p ≥ 0.05, **p < 0.01; p = 0.0034 (EdU+), p = 0.9926 (OLIG2+/BrdU+). Source data are provided as a Source Data file.

Back to article page